Rubicon Organics
(OTC) ROMJF
Rubicon Organics Financials at a Glance
Market Cap
$21.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
CA$60.78M
Net Income (TTM)
-CA$1.38M
EPS (TTM)
-$0.01
P/E Ratio
-24.33
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Price
$0.32
Volume
7,500
Open
$0.33
Price
$0.32
Volume
7,500
Open
$0.33
Previous Close
$0.32
Daily Range
$0.32 - $0.33
52-Week Range
$0.27 - $0.54
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Price
$0.32
Volume
7,500
Open
$0.33
Previous Close
$0.32
Daily Range
$0.32 - $0.33
52-Week Range
$0.27 - $0.54
Estimated Earnings Date
Aug 13, 2026
ROMJF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rubicon Organics
Industry
Pharmaceuticals
Sector
Health CareEmployees
210
CEO
Margaret Brodie, CPA
Website
www.rubiconorganics.comHeadquarters
Vancouver, BC V6C 1A5, CA
ROMJF Financials
Key Financial Metrics (TTM)
Gross Margin
20.98%
Operating Margin
-8.94%
Net Income Margin
-2.27%
Return on Equity
-3.16%
Return on Capital
-27.14%
Return on Assets
-2.09%
Earnings Yield
-4.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$21.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
67.18M
Volume
7.50K
Avg. Volume
28.90K
Financials (TTM)
Gross Profit
CA$5.81M
Operating Income
-CA$9.00M
EBITDA
-CA$5.28M
Operating Cash Flow
-CA$246.06K
Capital Expenditure
-CA$9.96M
Free Cash Flow
-CA$10.21M
Cash & ST Invst.
CA$3.21M
Total Debt
CA$13.47M
Rubicon Organics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$13.72M
+10.9%
Gross Profit
-CA$5.18M
-222.5%
Gross Margin
-37.72%
N/A
Market Cap
$21.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$103.74K
N/A
Employees
208
N/A
Net Income
-CA$2.76M
-756.7%
EBITDA
-CA$6.23M
-1109.0%
Quarterly Fundamentals
Total Cash
CA$3.21M
-58.8%
Total Debt
CA$13.47M
+38.9%
Accounts Receivable
CA$5.33M
-6.1%
Inventory
CA$21.23M
+51.3%
Long Term Debt
CA$11.29M
+35.9%
Short Term Debt
CA$2.17M
+56.0%
Return on Assets
-2.09%
N/A
Return on Invested Capital
-10.27%
N/A
Free Cash Flow
-CA$311.80K
+81.6%
Operating Cash Flow
CA$1.96M
+304.1%